Now Everyone Wants to Do Drug Discovery | GenomeWeb

The Wall Street Journal runs an article profiling multimillionaire and melanoma patient Jay Tenenbaum and the company he founded, CollabRx, to get patients involved in helping develop therapeutics faster and for less money than the process currently takes. The projects that CollabRx takes on are called "virtual biotechs," according to the story, "because they aim to replicate many of the steps typically taken as part of a pharmaceutical or biotech company's search for a new drug."

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.